Minister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup b...

“We ran out of Coronil tablets/kit over the last few weeks due to high demand,” said Kapil Pangasa, owner of a general store on Delhi’s Pri...

A clinical trial was conducted on 100 people in May-June last year and the results were "promising", the company said. The selected 100 par...

The Indian Medical Association (IMA) on Monday demanded an explanation from Union Health Minister Dr Harsh Vardhan for promoting Patanjali'...

Citing the case of a 30-year-old male health worker infected with coronavirus, the report said his infection was managed with Samshamana th...

Commenting on the development Dabur India Marketing Head-Healthcare OTC Ajay Singh Parihar said, "With the growing demand of baby care prod...

The claim triggered a row with the Union AYUSH ministry telling the herbal products firm not to sell the drug till it has examined the issu...

The ministry has also reached out to the Uttarakhand government to provide copies of license and approval details granted for the manufactu...

The advisory suggests intake of anti-malarial Ayurvedic drug, AYUSH 64, developed by the ministry, use of sesame oil in the nose, and tulsi...

Even though the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy (Ayush) has issued an advisory recommen...

The medicine is likely to be available in the market by next year.

As per the plan, Ayurvedic drug manufacturers would be invited to set up herbal drug production units in the state, based on PPP mode.

The Bengaluru-based company plans to make available a tablet in all its 150 outlets across the country for consumers to browse and order an...

Export of over 60 products, following the regulatory nod, has facilitated in treatment of Ayushakti's large patients base from Germany.

Ajanta Pharma rose more than 6 pc after Dabur India was in talks to buy '30-Plus' multi-vitamin supplement brand from Ajanta Pharma.

The deal is expected this week and will be under 50 crore, one of the officials said, requesting anonymity.

FMCG major Dabur, which owns the 'Hajmola' brand of digestive tablets, is unable to digest another pill by almost the same name - 'Pachmola...